MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape. - Wikidata - wikimedia - TriplyDB

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

http://www.wikidata.org/entity/Q34365811

about

MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.Study on the therapeutic effect of neural progenitor cells in mice of a glioma murine model Control of glioma cell migration and invasiveness by GDF-15 MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide.VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer MicroRNA-300 inhibited glioblastoma progression through ROCK1.MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?Therapeutic potential and challenges of natural killer cells in treatment of solid tumors The Dynamics of Interactions Among Immune and Glioblastoma Cells.MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression.MicroRNA and extracellular vesicles in glioblastoma: small but powerful.Vaccine-based immunotherapeutic approaches to gliomas and beyond.miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway.Biological activity of tumor-treating fields in preclinical glioma models.Regulation of IL-8 gene expression in gliomas by microRNA miR-93.Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells.Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids.NKG2D ligand expression in pediatric brain tumors.MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma.IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells.NKG2D and Its Ligands: "One for All, All for One".Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages.LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.

P2860

Q26779540-A7879689-5DCB-4A38-934F-D4258D85E879 Q33815894-2B11BA72-E943-45FF-84DF-2ED21FD6F365 Q35597405-48B72ADA-2D9F-45AF-B0EA-892C68F33E56 Q35626803-712E7ED8-5150-410C-B853-A6B1CB4A39BC Q36232099-FDE319E1-2C50-4746-864C-17161D2064AA Q36294437-0CB33992-AF16-4E92-ACFA-0952E77486BE Q36356011-B24DB3B9-FD89-42F0-A671-7BBC352F9A14 Q36650448-DAA6121F-D368-4F15-AD63-7DFB3495BD40 Q36946604-CBAE0935-D486-4853-8930-B519B6841CD0 Q37036256-6350EA4A-06E1-4E3A-B475-8B91F2BD71A9 Q37086056-A8A839AE-B2E6-4A4F-B0C3-CCFFC9FF5B72 Q37392761-86EB8649-E4A2-47E0-A1D1-514F9BD47E05 Q37667362-E39BEF65-E2F9-4BF2-8E6E-F08A7C5CE2D2 Q38478878-DB5DE229-DB90-413F-8FDC-E4DABD04823C Q38557236-6A3F7E11-D5EB-46BA-86CB-35F3FF4A8C4D Q38701227-4D637650-3647-4401-B6E4-00D61BAE2DA3 Q38770220-FE4414E3-41F8-4149-ADC8-5F42826BDF2A Q38789860-7B65D865-2D32-4CEB-9D81-DF92D0CDEA30 Q38792823-2D09CB34-29F8-4A12-BA45-89FBE4F4D355 Q38828969-0A034090-B258-4FA5-A069-D9BDA61CA62F Q38829417-462D6DA6-A984-442E-B610-DB3C1DD879B1 Q38829967-B7F40563-6F18-436C-BC98-4D91679EF991 Q38920264-3D507D50-5A7D-4B83-855A-683ECF8E74CA Q39196323-82E223BB-84E5-41CC-A4FA-1CA418D4B257 Q39990148-32C4CDD1-E912-40F8-9220-2E101DE21280 Q40213573-0374910F-D2AE-4582-9399-062423497EC7 Q41654263-9C5911BE-7CBA-4A53-922E-B58CB546C656 Q47129492-577CBE2C-D28C-4B04-9C45-601ECE467A4C Q50920191-DFC9F6C2-180B-4B75-8E98-3FA3AC59EC12 Q50976179-12B3D3D1-0958-48AD-8DCE-26E4DB9243FA Q54234609-7FF648F5-84A1-478E-BA22-D314DC1EC8A5 Q54979162-5BF9680C-F228-4CC2-B672-6636ECC6A7B3 Q55035860-D53BB893-20C9-41BC-BC00-F6ACFF049C13

P2860

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

http://www.wikidata.org/entity/Q34365811

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@ast

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@en

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@nl

type

label

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@ast

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@en

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@nl

prefLabel

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@ast

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@en

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@nl

P1433

Q34365811-1A7D533C-A92D-42B9-9D33-D30C97E8DC90

P1476

Q34365811-ABB3A335-A8AC-410B-ABEC-EEDF7FDAE010

P2093

Q34365811-047CAAE3-97DF-4334-847E-B3246830B8F0

Q34365811-0D3C882D-4713-45DE-B472-FC2555F34E83

Q34365811-3B24BC90-7AB2-4AFC-BBE8-7624AD69A3D4

Q34365811-70EB3719-672E-413E-96FB-91EE4FF3234A

Q34365811-79468493-CFFA-4AC1-92A5-D11F096E119B

P2860

Q34365811-05E592E8-42CE-4627-8203-F3E845BB8576

Q34365811-10C83068-84D3-4502-B561-BFB241A116B8

Q34365811-132DDD67-7CE8-4612-909E-05C62649B811

Q34365811-15968C3C-4AA2-46FF-B9B4-AD00F5397CB6

Q34365811-23E011F6-FB4D-4CE9-92DD-D3C4D1E7B98E

Q34365811-2627FC19-241B-46C6-A301-BE9D2B1B2A06

Q34365811-27B6E6F3-3054-4DE7-97EC-B6AC143C917F

Q34365811-2BC25E72-421B-49C0-AAB5-0E9F526E1884

Q34365811-2F3591DD-177A-41EA-A38D-EE61A1F11CD4

Q34365811-3C6DB844-175C-4F7E-AE50-A24637D2F811

P304

Q34365811-BCDEB11E-9C2A-4010-AF18-E2F8B647BC4F

P31

Q34365811-169C1EA2-85B6-4E53-96A9-0708ADA26497

P356

Q34365811-DAB09F3C-8C57-4798-B75A-9D18ABA26967

P407

Q34365811-7D2AB3D7-DB6C-45BD-9451-E60B66CF205E

P433

Q34365811-792A1203-5EB4-47CC-81B6-7F4CBBC70560

P478

Q34365811-DF6F7C23-8754-4278-8193-1A07D7A4B956

P50

Q34365811-45BF5A0F-CCA7-432D-BDF1-22C2DF068602

Q34365811-662C18C9-2E4A-4FB1-8AFD-AB1AA2B2D5DD

Q34365811-FABFD697-8F7E-426E-85E6-6E913952DEE3

P577

Q34365811-386619E6-8056-4C36-BC34-09ED3A8781EA

P698

Q34365811-63D72D41-3C14-4F25-8D9A-75D5AA313266

P921

Q34365811-F4F4ADBC-DA6B-421C-9941-78B3F7974E5C

P932

Q34365811-82B3E593-C145-4C63-9E0F-5CF9FC3E7A34

P356

ONCOTARGET.2287

P1433

P1476

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.

@en

P2093

Alexander Steinle

http://www.w3.org/2001/XMLSchema#string

Emese Szabo

http://www.w3.org/2001/XMLSchema#string

Gunter Meister

http://www.w3.org/2001/XMLSchema#string

Patrick Roth

http://www.w3.org/2001/XMLSchema#string

Paula Codo

http://www.w3.org/2001/XMLSchema#string

P2860

Human NKG2D-ligands: cell biology strategies to ensure immune recognition

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Hypoxia potentiates glioma-mediated immunosuppression

Regulation of ligands for the NKG2D activating receptor.

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy

Vitamin C is dispensable for oxygen sensing in vivo

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

P304

7651-7662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2287

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Guido Reifenberger

Marietta Wolter

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25277195

http://www.w3.org/2001/XMLSchema#string

P921

P932

4202151

http://www.w3.org/2001/XMLSchema#string